Copper: An Overview of Health-Related Aspects

1. Conditions Studied

Copper has been studied for a variety of health conditions, including, but not limited to:

• Anemia - due to its role in iron metabolism and red blood cell formation.
• Osteoporosis - as it is essential for bone health and collagen production.
• Cardiovascular diseases - copper is known to have a role in maintaining heart health and blood vessel function.
• Immune system deficiencies - owing to its importance in immune system performance.
• Neurodegenerative diseases - its potential effects on brain health are being explored.

2. Efficacy in Treating Conditions

The effectiveness of copper in treating specific conditions is mixed and often depends on the presence of a deficiency. For instance:

• In cases of copper deficiency, supplementation can help alleviate anemia and improve bone health.
• There is no strong evidence that copper supplementation improves cardiovascular health in individuals without a deficiency.
• While copper plays a role in immune function, there is limited evidence on the benefits of supplementation for immune system deficiencies.

3. Health Benefits

Copper is known to contribute to several aspects of health, including:

• Formation of red blood cells and iron absorption.
• Supporting healthy bones, blood vessels, nerves, and immune function.
• Acting as an antioxidant by scavenging damaging free radicals.
• Assisting in energy production within cells.

4. Downsides

Despite its benefits, copper can have downsides, such as:

• Copper toxicity, which can occur from excessive intake, leading to liver damage and other health issues.
• Interference with zinc absorption when taken in high amounts, potentially leading to a zinc deficiency.
• Gastrointestinal discomfort if consumed in large quantities.

5. Genetic Variations

Genetic variations can influence how copper affects the body:

• Individuals with Wilson's disease, a genetic disorder, accumulate copper in tissues, leading to liver disease and neurological symptoms.
• Menkes disease, another genetic condition, results in poor copper absorption and can lead to deficiency.
• There are also genetic variations that may affect copper metabolism, but the implications of these on health are not fully understood.

It is important to consult with a healthcare professional before starting any supplement regimen, especially for those known or suspected to have genetic variations affecting copper metabolism.

Research Summary on Copper

The research explores copper's essential role in various metabolic functions and its interaction with other dietary elements. Critical findings highlight copper's importance in enzymatic reactions and immune system function, with deficiencies leading to health issues such as anemia, weakened immunity, and neurological disorders.

Main Points:

• Copper is crucial for metabolic functions and is a component of enzymes (cuproenzymes).
• Techniques like atomic absorption spectrophotometry have advanced the understanding of copper's absorption and metabolism.
• Recommended Dietary Allowances (RDAs) for copper are provided based on age and gender.
• Excessive alcohol consumption can lead to minor copper intake variability.
• Prokaryotic organisms have varied copper usage patterns, with aerobic organisms utilizing copper more than anaerobic ones.
• Copper's role in neurodegenerative conditions like Alzheimer's disease is being studied, suggesting a link between copper metabolism and the disease.
• Dietary copper intake is often insufficient despite its widespread presence in foods, potentially leading to health issues.
• Emerging research suggests copper imbalance may contribute to Alzheimer's disease, with "free" copper being a factor.

Potential Health Implications:

• Copper deficiency can lead to anemia, neutropenia, and compromised immunity.
• Genetic factors can result in copper toxicity, such as in Wilson's disease.
• Long-term marginal copper deficiency can cause heart damage in rats, suggesting potential cardiovascular risks.
• High copper intake partnered with a high-fat diet may accelerate cognitive decline.

Recommendations:

• Adult males should consume at least 2 mg of copper per day to maintain balance.
• Contemporary diets may require increased copper to prevent deficiencies.
• Further research is needed to understand the role of copper in Alzheimer's and other neurodegenerative diseases.

Conclusions:

The studies collectively underscore copper's significant impact on human health, necessitating proper dietary intake and further research into copper-related health conditions.

References:

1. Dietary sources of nutrients among US adults, 1989 to 1991
2. Dietary exposure to copper in the European Union and its assessment for EU regulatory risk assessment
3. A review of the biochemical roles, toxicity and interactions of zinc, copper and iron: II. Copper
4. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc
5. Comparative genomic analyses of copper transporters and cuproproteomes reveal evolutionary dynamics of copper utilization and its link to oxygen
6. Mechanism of the peroxidase activity of Cu, Zn superoxide dismutase
7. Structure and mechanism of copper, zinc superoxide dismutase
8. Electrostatic recognition between superoxide and copper, zinc superoxide dismutase
9. CO2, not HCO3-, facilitates oxidations by Cu,Zn superoxide dismutase plus H2O2
10. Rate constants for the reaction of the carbonate radical with compounds of biochemical interest in neutral aqueous solution
11. The carbonate radical and related oxidants derived from bicarbonate buffer
12. Carbon dioxide mediates Mn(II)-catalyzed decomposition of hydrogen peroxide and peroxidation reactions
13. The effect of copper deficiency on the immune response in mice
14. Immune dysfunction in rats fed a diet deficient in copper
15. Copper and immunity
16. Copper deficiency in humans
17. Low-copper diet as a preventive strategy for Alzheimer's disease
18. Dietary and lifestyle guidelines for the prevention of Alzheimer's disease
19. Copper absorption and retention in young men at three levels of dietary copper by use of the stable isotope 65Cu
20. Contrasting effects of low or high copper intake on rat tissue lipid essential fatty acid composition
21. Nutrient deficiencies after gastric bypass surgery
22. Myelopathy due to copper deficiency following gastrointestinal surgery
23. PPIs as possible risk factor for copper deficiency myelopathy
24. Marginal copper deficiency increases liver neutrophil accumulation after ischemia/reperfusion in rats
25. Marginal dietary copper restriction induces cardiomyopathy in rats
26. Marginal copper-restricted diets produce altered cardiac ultrastructure in the rat
27. Relationship between dietary copper concentration and acetylcholine-induced vasodilation in the microcirculation of rats
28. Hemostatic mechanisms in marginally copper-deficient rats
29. Cyclooxygenase-2 is upregulated in copper-deficient rats
30. Augmented metalloproteinase activity and acute lung injury in copper-deficient rats
31. Tissue-specific ICAM-1 expression and neutrophil transmigration in the copper-deficient rat
32. Congestive heart failure in copper-deficient mice
33. Cardiac ultrastructural and electrophysiological abnormalities in postweanling copper-restricted and copper-repleted rats in the absence of hypertrophy
34. Regression of dietary copper restriction-induced cardiomyopathy by copper repletion in mice
35. Copper deficiency myelopathy: A report of two cases
36. Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration
37. Imaging features of copper deficiency myelopathy: a study of 25 cases
38. Changes in copper and zinc serum levels in women wearing a copper TCu-380A intrauterine device
39. Intrauterine device and maternal copper metabolism during lactation
40. Studies on the nature of complexes formed by copper with human alimentary secretions and their influence on copper absorption in the rat
41. ABSORPTION OF CU-64, ZN-65, MO-99, AND FE-59 FROM LIGATED SEGMENTS OF THE RAT GASTROINTESTINAL TRACT
42. Contrasting effects of the stomach and small intestine of rats on copper absorption
43. Risks of copper and iron toxicity during aging in humans
44. Treatment of Wilson's disease with zinc. II. Validation of oral 64copper with copper balance
45. Cloning, expression, and vesicular localization of zinc transporter Dri 27/ZnT4 in intestinal tissue and cells
46. A comparative study on the possible zinc binding sites of the human ZnT3 zinc transporter protein
47. DMT1, a physiologically relevant apical Cu1+ transporter of intestinal cells
48. Iron, copper, and zinc transport: inhibition of divalent metal transporter 1 (DMT1) and human copper transporter 1 (hCTR1) by shRNA
49. Amino acid facilitates absorption of copper in the Caco-2 cell culture model
50. Copper absorption and bioavailability
51. A stable isotope study of copper absorption in young men: effect of phytate and alpha-cellulose
52. Intestinal metallothionein and the mutual antagonism between copper and zinc in the rat
53. The effect of dietary zinc on intestinal copper absorption
54. Copper alone, but not oxidative stress, induces copper-metallothionein gene in Neurospora crassa
55. Copper and zinc absorption in the rat: mechanism of mutual antagonism
56. The effects of phytate on intestinal absorption and secretion of zinc, and whole-body retention of Zn, copper, iron and manganese in rats
57. Effect of dietary protein and phosphorus levels on the utilization of zinc, copper and manganese by adult males
58. Copper bioavailability and requirements
59. COPPER DEFICIENCY IN RATS FED UPON RAW MEAT
60. Wilson's disease
61. Treatment of Wilson's disease with tetrathiomolybdate: V. Control of free copper by tetrathiomolybdate and a comparison with trientine
62. Wilson's disease patients with normal ceruloplasmin levels
63. Free copper distinguishes mild cognitive impairment subjects from healthy elderly individuals
64. Copper phenotype in Alzheimer's disease: dissecting the pathway
65. Copper biochemistry and molecular biology
66. Association of oxidative stress to the genesis of anxiety: implications for possible therapeutic interventions
67. High-affinity copper block of GABA(A) receptor-mediated currents in acutely isolated cerebellar Purkinje cells of the rat
68. An N-terminal histidine is the primary determinant of alpha subunit-dependent Cu2+ sensitivity of alphabeta3gamma2L GABA(A) receptors
69. Role of GABA in anxiety and depression
70. Comparative analysis of serum zinc, copper, manganese, iron, calcium, and magnesium level and complexity of interelement relations in generalized anxiety disorder patients
71. Decreased zinc and increased copper in individuals with anxiety
72. Is serum copper a "trait marker" of unipolar depression? A preliminary clinical study
73. The plasma concentration of copper and prevalence of depression were positively correlated in shift nurses
74. Elevated serum copper levels in women with a history of post-partum depression
75. Analysis of plasma zinc and copper concentration, and perceived symptoms, in individuals with depression, post zinc and anti-oxidant therapy
76. Cardiovascular disease from copper deficiency--a history
77. Copper: an antioxidant nutrient for cardiovascular health
78. Serum ceruloplasmin level and the risk of myocardial infarction and stroke
79. Serum copper concentration and coronary heart disease among US adults
80. A copper(II)-selective chelator ameliorates left-ventricular hypertrophy in type 2 diabetic patients: a randomised placebo-controlled study
81. Elevated circulating levels of copper and nickel are found in elderly subjects with left ventricular hypertrophy
82. A randomized trial of copper supplementation effects on blood copper enzyme activities and parameters related to cardiovascular health
83. PAI-1 and atherothrombosis
84. Effect of copper supplementation on indices of copper status and certain CVD risk markers in young healthy women
85. Serum level of copper in patients with coronary artery disease
86. Modifications of magnesium and copper concentrations in serum and arterial wall of patients with vascular diseases related to ageing, atherosclerosis and aortic aneurysm
87. Anti-oxidant status and lipid peroxidation in patients with essential hypertension
88. Copper supplementation of adult men: effects on blood copper enzyme activities and indicators of cardiovascular disease risk
89. Copper supplementation at 8 mg neither affects circulating lipids nor liver function in apparently healthy Chilean men
90. Copper supplementation in humans does not affect the susceptibility of low density lipoprotein to in vitro induced oxidation (FOODCUE project)
91. Copper, chromium, manganese, iron, nickel, and zinc levels in biological samples of diabetes mellitus patients
92. Concentrations of seven trace elements in different hematological matrices in patients with type 2 diabetes as compared to healthy controls
93. Copper, zinc, manganese, and magnesium status and complications of diabetes mellitus
94. Increase in total antioxidant capacity of plasma despite high levels of oxidative stress in uncomplicated type 2 diabetes mellitus
95. Plasma mineral content in type-2 diabetic patients and their association with the metabolic syndrome
96. Plasma, granulocyte and mononuclear cell copper and zinc in patients with diabetes mellitus
97. Altered metabolism of copper, zinc, and magnesium is associated with increased levels of glycated hemoglobin in patients with diabetes mellitus
98. Copper and zinc distribution in the human retina: relationship to cadmium accumulation, age, and gender
99. Superoxide dismutase isoenzymes in the human eye
100. Effect of experimentally induced chronic copper toxicity on retina
101. Cadmium accumulation in the human retina: effects of age, gender, and cellular toxicity
102. Review of nutrient actions on age-related macular degeneration
103. The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1
104. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8
105. Lifestyle modification, nutritional and vitamins supplements for age-related macular degeneration
106. Impaired deformability of copper-deficient neutrophils
107. Proinflammatory effects of copper deficiency on neutrophils and lung endothelial cells
108. Elemental analysis of Mycobacterium avium-, Mycobacterium tuberculosis-, and Mycobacterium smegmatis-containing phagosomes indicates pathogen-induced microenvironments within the host cell's endosomal system
109. Respiratory burst and candidacidal activity of peritoneal macrophages are impaired in copper-deficient rats
110. Recent developments in trace element metabolism and function: trace elements, disease resistance and immune responsiveness in ruminants
111. The Janus face of copper: its expanding roles in biology and the pathophysiology of disease. Meeting on Copper and Related Metals in Biology
112. A role for the ATP7A copper-transporting ATPase in macrophage bactericidal activity
113. The effect of tripeptide-copper complex on human hair growth in vitro
114. Analysis of serum zinc and copper concentrations in hair loss
115. Trace element levels in alopecia areata
116. BMI and levels of zinc, copper in hair, serum and urine of Turkish male patients with androgenetic alopecia
117. Emergency contraception with a copper IUD or oral levonorgestrel: an observational study of 1-year pregnancy rates
118. Contraceptive efficacy of the Copper T380A and the Multiload Cu250 IUD in three developing countries
119. Comparative study on contraceptive efficacy and clinical performance of the copper/low-density polyethylene nanocomposite IUD and the copper T220C IUD
120. Consequences of uterine blood loss caused by various intrauterine contraceptive devices in South American women. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction
121. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices
122. Treatment of bleeding irregularities in women with copper-containing IUDs: a systematic review
123. Therapeutics for Alzheimer's disease based on the metal hypothesis
124. Copper in Alzheimer's disease: a meta-analysis of serum,plasma, and cerebrospinal fluid studies
125. The risks of copper toxicity contributing to cognitive decline in the aging population and to Alzheimer's disease
126. Serum copper, zinc and copper/zinc ratio in males: influence of aging
127. New evidence on iron, copper accumulation and zinc depletion and its correlation with DNA integrity in aging human brain regions
128. The effects of chronic copper exposure on the amyloid protein metabolisim associated genes' expression in chronic cerebral hypoperfused rats
129. Copper chelator induced efficient episodic memory recovery in a non-transgenic Alzheimer's mouse model
130. The Alzheimer's disease amyloid precursor protein modulates copper-induced toxicity and oxidative stress in primary neuronal cultures
131. The distribution profile and oxidation states of biometals in APP transgenic mouse brain: dyshomeostasis with age and as a function of the development of Alzheimer's disease
132. New insights on how metals disrupt amyloid beta-aggregation and their effects on amyloid-beta cytotoxicity
133. The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction
134. Cupric-amyloid beta peptide complex stimulates oxidation of ascorbate and generation of hydroxyl radical
135. Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction
136. Neurodegenerative diseases and oxidative stress
137. Cu(II) potentiation of Alzheimer Abeta1-40 cytotoxicity and transition on its secondary structure
138. Copper hypothesis in the missing hereditability of sporadic Alzheimer's disease: ATP7B gene as potential harbor of rare variants
139. Linkage disequilibrium and haplotype analysis of the ATP7B gene in Alzheimer's disease
140. The role of MT in neurological disorders
141. Significance of metallothioneins in aging brain
142. Regulation of metallothionein genes by heavy metals appears to be mediated by a zinc-sensitive inhibitor that interacts with a constitutively active transcription factor, MTF-1
143. The transcription factor MTF-1 is essential for basal and heavy metal-induced metallothionein gene expression
144. Metallothionein: an intracellular protein to protect against cadmium toxicity
145. Metallothioneins: mercury species-specific induction and their potential role in attenuating neurotoxicity
146. Zinc-induced copper deficiency: a report of three cases initially recognized on bone marrow examination
147. Fatal copper deficiency from excessive use of zinc-based denture adhesive
148. Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease
149. CNS demyelination associated with copper deficiency and hyperzincemia
150. CNS demyelination from zinc toxicity?
151. Pharmacologic role of cysteine in ameliorating or exacerbating mineral toxicities
152. Influence of ascorbic acid on the absorption of copper by rats
153. Copper-amino acid complexes are partially protected against inhibitory effects of L-cysteine and L-ascorbic acid on copper absorption in chicks

Upload Whole Genome Sequencing (WGS) raw DNA data today and take a deep dive into your genome!

Or if you only have standard microarray data currently, upload raw DNA data to get started with your free DNA raw data analysis today!